(Chest. 2004;125:2351-2356.)
© 2004
American College of Chest Physicians
Enhanced Alveolar Clearance With Chest Percussion Therapy and Positional Changes During Whole-Lung Lavage for Alveolar Proteinosis*
Andrew Perez, IV, MD and
Robert M. Rogers, MD, FCCP
* From the Division of Pulmonary, Allergy and Critical Care Medicine (Dr. Perez), and the Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease (Dr. Rogers), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Correspondence to: Robert M. Rogers, MD, FCCP Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, NW 628 MUH, 3459 Fifth Ave, Pittsburgh, PA 15213; e-mail: rogersrm{at}upmc.edu
 |
Abstract
|
|---|
Pulmonary alveolar proteinosis has traditionally been treated with whole-lung lavage (WLL). The literature describes a variety of techniques used in performing the WLL, including mechanical vs manual chest percussion, use of prone positioning, and variances in lavage volume. We have quantified and compared the effective alveolar clearance for each component of the lavage by measuring the dry weight of material in the lavage effluent. We measured this in five patients who underwent six consecutive WLLs at the University of Pittsburgh Medical Center. We performed the lavage in the following three stages: stage I, passive drainage; stage II, assisted clearance; and stage III, positional clearance. Aliquots of lavage effluent were centrifuged to determine the dry weight of material present in sequentially recorded bottles within each stage. At the initiation of each augmentation, there was a statistically significant improvement in the clearance of material (stage II, p = 0.009; stage III, p = 0.012). Furthermore, we show that lipoproteinaceous material is present in the lavage effluent in all stages of latter portions of the lavage. The effective removal of material would be expected to have an impact on the physiologic and clinical response to WLL. This finding emphasizes the importance of performing an adequate and standardized lavage.
Key Words: alveolar proteinosis lung diseases pulmonary BAL respiratory tract diseases
 |
Introduction
|
|---|
Pulmonary alveolar proteinosis (PAP) is a disease characterized by the accumulation of lipoproteinaceous material within the alveolar spaces.123 The most common therapeutic intervention for this disorder has been whole-lung lavage (WLL).24 We have performed WLL on > 100 patients with PAP since 1968. WLL in patients with PAP has been associated with a reduction in dyspnea and improved physiologic parameters.456 The clinical and physiologic response to WLL has been attributed to the removal of lipoproteinaceous material from the alveolar space.3 To maximize the effectiveness of alveolar clearance, we have modified our previously published technique.678 Our technique now focuses on large-volume WLL (ie, 40 to 70 L per lung), positional clearance with prone positioning for the last 10 to 15 L fluid, and assisted clearance using vigorous manual chest physical therapy.910 Our clinical impression is that this technique has resulted in more complete clearing of the lung fields and in longer remissions of the disease process, but we do not have data to substantiate that impression. The purpose of this study was to measure the effectiveness of each component in our WLL process by measuring the dry weight of material obtained during isolated fluid lavage, as well as positional and assisted lung clearance techniques.
 |
Materials and Methods
|
|---|
We studied five patients who were underwent a total of six consecutive WLLs performed at the University of Pittsburgh Medical Center between February 2001 and February 2003. These patients required lung lavage based on clinical and physiologic criteria.11 Spirometry, lung volume measurements, and diffusing capacity of the lung for carbon monoxide (DLCO) measurements were performed before and after the lavage procedure using American Thoracic Society standards. The Institutional Review Board of the University of Pittsburgh approved the study, and all patients provided informed consent to participate in this study.
Lavage Procedure
The patients were intubated with a double-lumen endotracheal tube, with confirmation of appropriate placement by fiberoptic bronchoscopy. The isolation of each lung was confirmed by water seal testing at 50 to 60 mm Hg pressure. The designated lung was lavaged with warmed normal sterile saline solution (37°C), with total volumes ranging from 45 to 60 L (ie, high-volume lavage). The initial lavages were performed using aliquots of 250 to 500 mL and were gradually titrated up to approximately 50% of the previously measured functional residual capacity. Effluent was collected in sequentially numbered 1.5-L bottles. The lung lavage was performed in three sequential stages. Stage I reflected the initial portion with the patient in the supine position, during which time there was instillation and removal of fluid until the effluent appeared to be clear. Stage II represents assisted clearance with vigorous manual chest percussion until the fluid again was clear. Percussion was administered during both instillation and removal, but more vigorously during effluent drainage. Finally, stage III involved positional clearance in which the patient was placed in the prone position with continuation of chest percussion during lavage and the effluent was collected until it was clear. At that point, the procedure was terminated. The sequentially numbered bottles were marked to identify the transition from one stage to the next. A new bottle was used at each of these points.
Weighing Materials
Since the majority of the solid material in the effluent is surfactant, we used a method based on a previously described technique for isolating surfactant.12 All bottles of effluent were stored at 4°C until they could be analyzed. The lipoproteinaceous material tends to settle over time due to gravity, so the material was resuspended by vigorously agitating the bottles prior to withdrawing a 250-mL aliquot from each bottle. The aliquot was centrifuged at 27,500g for 50 min. The supernatant was discarded, and the dry weight of the pellet was measured. The volume of effluent remaining in the bottle was determined using a 2-L graduated cylinder. The total weight for each bottle was calculated by the weight of the pellet multiplied by the ratio of the total volume of fluid in the bottle divided by the aliquot volume (250 mL). We were thus able to estimate the dry weight of material in each bottle.
Data Summary and Statistical Analysis
The dry weight of the material in each sequential bottle was noted. The dry weight of the bottle prior to and at each transition stage was noted. We summarized the cumulative dry weight of material during each of the three major parts of the procedure. To account for the large variability in the weight of the material being removed, we also expressed this in terms of the percentage of total material for the three stages of the procedure. We summarized the weight of the effluent for each individual bottle vs the sequential bottle number, indicating the points of major intervention, or stages. The mean, SD, and range were determined for volume, weight, and percentage weight at all three stages of the lavage procedure. A paired Student t test was performed on the data from pulmonary function tests (PFTs) before and after lung lavage. The significance of the difference in terms of the dry weight of the last bottle prior to and after each stage transition was determined using a paired t test. All statistical analyzes were performed using a statistical software program (Minitab, release 13.31; Minitab Inc; State College, PA).
 |
Results
|
|---|
The average amount of saline solution used, the total amount used, and the amount for each stage used for the 12 WLLs are summarized in Table 1
. The right lung lavage in the first lavage set in patient 4 was terminated after the patient was placed in the prone position due to displacement of the bronchial cuff of the endotracheal tube. No additional complications during the lavage of the other patients were recognized. The dry weight of the material collected during the lavage procedures ranged from 30.9 to 387 g, with a mean of 199 ± 104 g. The mean percentage of material being removed in each stage was as follows: stage I, 32.1% ± 21.7%; stage II, 57.4% ± 19.9%; and stage III, 10.5% ± 6.1% (Table 2
).
The effluent dry weight was recorded for each bottle, sequentially. This was then graphed with the designation of time points for the initiation of stages I and III. A representative graph from a single lavage is illustrated in Figure 1
. We also noted the weight in each bottle prior to and at the initiation of each intervention, and these are shown in Table 3
.

View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1. Representative graph from a single lavage showing the weight of the effluent in each individual bottle arranged sequentially over the time period of the lung lavage. This illustrates the improvement in effluent dry weight after each intervention and the variability during chest percussion. CPT Start = chest percussion therapy initiation time; Prone Start = prone positioning initiation time.
|
|
View this table:
[in this window]
[in a new window]
|
Table 3. Effectiveness of Manual Chest Percussion and Prone Positioning; Dry Weight in Bottles Prior to and After Initiation of Manual Chest Percussion and Prone Positioning*
|
|
Figure 2
shows the PFT changes in FVC and DLCO for all the patients before and after lung lavage was performed. All patients noted an improvement in their PFT results after WLL. The p values for the changes in FVC, FEV1, and DLCO before and after lavage were < 0.01, 0.10, and 0.01, respectively. Note that the fourth patient required two complete sets of bronchopulmonary lavage to produce a complete physiologic remission due to the severity of disease (DLCO changed from 25% to 43% predicted after the first set and 43% to 60% predicted after the second). There was physiologic improvement with both sets of lavages; however, only the second set produced a clinical resolution of dyspnea.
 |
Discussion
|
|---|
In this study, we found that the application of different maneuvers is superior to a single maneuver in clearing solid material from the lungs of PAP patients during WLL. A potential limitation of our study was the nonrandom application of the maneuvers. This was mandated by our clinical experience, in which we have observed that initiating chest percussion in the first stage may enhance the removal of material to the extent that the endotracheal tube becomes obstructed or is displaced. In addition, during the initial application of titrated saline solution lavage (ie, stage I) it is essential to establish proper fluid dynamics for the system, and to assure endotracheal tube placement and stability. These issues notwithstanding, our study does provide objective evidence attesting to the benefit of incorporating a variety of clinically relevant maneuvers in the WLL paradigm. We also recognize that our data were derived from a relatively small population. Nonetheless, the patients are highly representative of the PAP phenotype, and the qualitatively similar result across all study participants adds credence to the generalizability of our observations and conclusions.
As shown in Table 2, the weight of the material being removed was highest in almost all patients while chest percussion was being performed. Prone positioning appears to have a small cumulative influence on the amount of material being removed. The wide range of weights obtained is related to variations in the severity of the disease and the diversity of body size in the patients.
The representative graph of bottle number vs material weight (Fig 1) shows that there was a tapering in the amount of material being collected after the initiation of lavage until the initiation of chest percussion. The amount of material increases with the administration of chest percussion therapy, but then again begins to taper. We also noted variations in the weight of material during the time period when chest percussion therapy was used, which we believe is related to variability in the intensity of the manual percussion. Table 3 shows the weight of the material in the individual bottles immediately before and after each intervention. We demonstrated a statistically significant increase in the material being removed after chest percussion and prone positioning each were started. The weight of material in the individual bottles was noted to increase immediately after prone positioning, when compared to the weights just prior to the position change. We used prone positioning because we noted that patients who had significant disease in the posterior segments did not clear these areas when lavage was performed only in the supine position. Even though the weight of the material removed in the prone position is only 10.5 ± 6.1% of the total, it appears radiographically to make a difference in the clearing of the posterior segments. Our data demonstrate that we are able to improve the amount of material in the effluent with the use of prone positioning.
We have shown that measurable amounts of lipoproteinaceous material were removed at all stages of lung lavage. The most effective adjunct to lavage is manual chest percussion therapy, removing 57 ± 19.9% of the total amount of material. Previous studies10 have suggested that manual chest percussion was superior to both mechanical percussion and no-percussion techniques using optical density changes. However, these authors did not measure the dry weight of lipoproteinaceous material in the effluent, so a direct comparison to our results cannot be made. The effect of prone positioning in facilitating the removal of lipoproteinaceous material was not as dramatic as that during stages I and II, but was still noted to be significant. This finding may be a result of using the technique at the terminal end of the procedure and not at the beginning.
To our knowledge, no studies have been performed comparing low-volume to high-volume lung lavage. Removing larger amount of material would presumably improve the patients physiologic parameters and gas exchange. Other authors have published single case reports on variations in lavage technique, such as fiberoptic bronchoscopy13 and partial ventilation of the lavaged lung.1415 The semi-quantitative technique that we have described would provide a method for future investigators to examine the relationship between the volume and the dry weight of material removed during WLL. Such a technique could eventually be used to study outcome variables such as pulmonary function, roentgenographic clearing, and length of remission. The current study is too small to address outcome, but when we compared the dry weight of the material removed to the change in DLCO, there was a modest correlation (r = 0.55), suggesting that as more material is removed, the DLCO increases. In this group of patients, none have required a repeat lavage during a follow-up period ranging from 10 to 36 months, although patient 4 required two complete sets of lavages before he had maximum clinical improvement.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been postulated1617181920 to be a useful treatment of PAP, based on the presence of antibodies to GM-CSF in patients with PAP. Studies212223 have shown that some patients experience clinical and physiologic improvement after the administration of GM-CSF. These studies are promising in the pursuit of a less invasive, more readily available treatment for PAP. However, in order to make valid comparisons among outcomes of WLL, GM-CSF, or any other treatment modality, a standardization of the WLL technique would be required. As we have shown, substantial amounts of lipoproteinaceous material are removed at the latter stages of the procedure, and the amount of material removed varies with adjunctive procedures used during the lavage. Our lavage technique may provide a basis from which such a standard may be developed. It would be useful to study the effectiveness of the randomization of the adjunctive procedures and even high-volume vs low-volume lung lavage. Given the limited pool of patients with this rare disease, a unified multicenter approach would be optimal.
 |
Acknowledgements
|
|---|
The authors thank the members of the Department of Anesthesia at the University of Pittsburgh Medical Center for their support and excellent anesthesia, the members of the Respiratory Therapy Department at the University of Pittsburgh Medical Center, especially David Pruszynski, RRT, and his students and staff who conducted the chest percussion for our WLLs, and our pulmonary function laboratory staff and the pulmonary fellows who assisted at each lavage. We also thank Drs. Mark Sanders and Alison Morris for their comments and review of the manuscript.
 |
Footnotes
|
|---|
Abbreviations: DLCO = diffusing capacity of the lung for carbon monoxide; GM-CSF = granulocyte-macrophage colony-stimulating factor; PAP = pulmonary alveolar proteinosis; PFT = pulmonary function test; WLL = whole-lung lavage
This research was supported by the George Love Fund.
Received for publication June 6, 2003.
Accepted for publication February 20, 2004.
 |
References
|
|---|
- Rosen, SH, Castleman, B, Liebow, AA (1958) Pulmonary alveolar proteinosis. N Engl J Med 258,1123-1142[ISI][Medline]
- Shah, PL, Hansell, D, Lawson, PR, et al Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000;55,67-77[Free Full Text]
- Kavuru, MS, Popovich, M Therapeutic whole lung lavage: a stop-gap therapy for alveolar proteinosis. Chest 2002;122,1123-1124[Free Full Text]
- Seymour, JF, Presneill, JJ Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166,215-235[Abstract/Free Full Text]
- Seidman, JM, Sasahara, AA Bronchopulmonary lavage. N Engl J Med 1972;286,1262-1263[Medline]
- Rogers, RM, Levin, DC, Gray, BA, et al Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978;118,255-264[ISI][Medline]
- Rogers, RM, Szidon, JP, Shelburne, J, et al Hemodynamic response of the pulmonary circulation to bronchopulmonary lavage in man. N Engl J Med 1972;286,1230-1233[ISI][Medline]
- Martin, RJ, Rogers, RM, Myers, NM Pulmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis. Am Rev Respir Dis 1978;117,1059-1062[ISI][Medline]
- Claypool, WD, Rogers, RM, Matuschak, GM Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984;85,550-558[Free Full Text]
- Hammon, WE, McCaffree, DR, Cucchiara, AJ A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest 1993;103,1409-1412[Abstract/Free Full Text]
- Rogers, RM, Levin, DC, Gray, BA, et al Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978;118,255-264[ISI][Medline]
- Strong, P, Kishore, U, Morgan, C, et al A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J Immunol Methods 1998;220,139-149[CrossRef][ISI][Medline]
- Cheng, SL, Chang, HT, Lau, HP, et al Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest 2002;122,1480-1485[Abstract/Free Full Text]
- Bingisser, R, Kaplan, V, Zollinger, A, et al Whole-lung lavage in alveolar proteinosis by a modified lavage technique. Chest 1998;113,1718-1719[Abstract/Free Full Text]
- Ishikawa, NKK, Oguri, T, Kamitsuna, M, et al Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis. Intern Med 2002;41,381-385[Medline]
- Bonfield, TL, Russell, D, Burgess, S, et al Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002;27,481-486[Abstract/Free Full Text]
- Bonfield, TL, Kavuru, MS, Thomassen, MJ Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol 2002;105,342-350[CrossRef][ISI][Medline]
- Tanaka, N, Watanabe, J, Kitamura, T, et al Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 1999;442,246-250[CrossRef][ISI][Medline]
- Carraway, MS, Ghio, AJ, Carter, JD, et al Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161,1294-1299[Abstract/Free Full Text]
- Kitamura, T, Uchida, K, Tanaka, N, et al Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;162,658-662[Abstract/Free Full Text]
- Seymour, JF, Presneill, JJ, Schoch, OD, et al Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001;163,524-531[Abstract/Free Full Text]
- Kavuru, MS, Sullivan, EJ, Piccin, R, et al Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161,1143-1148[Abstract/Free Full Text]
- Barraclough, RM, Gillies, AJ Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 2001;56,664-665[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
A. Perez IV, H. O. Coxson, J. C. Hogg, K. Gibson, P. F. Thompson, and R. M. Rogers
Use of CT Morphometry To Detect Changes in Lung Weight and Gas Volume
Chest,
October 1, 2005;
128(4):
2471 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|